Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
- PMID: 9539333
- DOI: 10.1002/mds.870130205
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
Abstract
The cause and mechanism of neuronal cell death in the substantia nigra of patients with Parkinson's disease (PD) are unknown. There is also controversy about whether the cell death results from a single event followed by cell loss consistent with aging or whether there is an ongoing pathologic process. Using postmortem tissue obtained from the Parkinson's Disease Society Brain Tissue Bank in London, we have sought to establish whether apoptosis, or more specifically DNA fragmentation of neurons, is a prominent feature of nigral pathology. In addition, we have studied microglial activation in the substantia nigra as an indicator of ongoing pathology using the highly sensitive markers CR3/43 and EBM11. Reactive astrocytes have been assessed using immunostaining for glial fibrillary acidic protein (GFAP). Ten patients with pathologically proven PD were studied. In all cases, regardless of disease duration, severity, drug treatment, or age of the patient, there was no evidence of apoptosis in the substantia nigra as assessed by in situ end-labeling of DNA fragments using biotinylated dUTP and terminal deoxynucleotidyl transferase (TdT). In contrast, a case of multiple system atrophy (MSA) served as a positive control for the technique. In this case, positive DNA end-labeling could be found in neurons and non-neuronal cells in the brain stem. In the PD cases, there was, however, localized pathology in the substantia nigra as revealed by the CR3/ 43 and EBM11 markers for activated microglia. This process seemed independent of disease duration and was florid even in patients with severe neuronal loss. It remains to be determined to what extent the activation of glial cells reflects progressive nigral pathology, and whether those factors which are classically associated with prominent apoptotic neuronal cell death in vivo, such as neurotrophic factor deprivation, are prime causes of nigral neuronal loss in PD. Future studies should focus on recent-onset PD or incidental Lewy body disease to further address these questions.
Comment in
-
Dopaminergic neurons degenerate by apoptosis in Parkinson's disease.Mov Disord. 1999 Mar;14(2):383-5. doi: 10.1002/1531-8257(199903)14:2<383::aid-mds1037>3.0.co;2-f. Mov Disord. 1999. PMID: 10091646 No abstract available.
Similar articles
-
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14. Neuroscience. 2006. PMID: 16533572
-
DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?Mov Disord. 1998 Nov;13(6):877-84. doi: 10.1002/mds.870130604. Mov Disord. 1998. PMID: 9827610
-
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.Brain Res. 2010 Apr 22;1326:174-83. doi: 10.1016/j.brainres.2010.02.045. Epub 2010 Feb 20. Brain Res. 2010. PMID: 20176003
-
Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?Int Rev Neurobiol. 2007;82:235-46. doi: 10.1016/S0074-7742(07)82012-5. Int Rev Neurobiol. 2007. PMID: 17678964 Review.
-
Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.Cell Tissue Res. 2004 Oct;318(1):149-61. doi: 10.1007/s00441-004-0944-0. Epub 2004 Aug 24. Cell Tissue Res. 2004. PMID: 15338271 Review.
Cited by
-
Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells.Cells. 2021 May 7;10(5):1124. doi: 10.3390/cells10051124. Cells. 2021. PMID: 34066933 Free PMC article. Review.
-
An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease.Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10918-23. doi: 10.1073/pnas.191107398. Epub 2001 Sep 4. Proc Natl Acad Sci U S A. 2001. PMID: 11535810 Free PMC article.
-
Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.Clin Neurosci Res. 2006 Dec 6;6(5):261-281. doi: 10.1016/j.cnr.2006.09.006. Clin Neurosci Res. 2006. PMID: 18060039 Free PMC article.
-
Striatal neuroinflammation promotes Parkinsonism in rats.PLoS One. 2009;4(5):e5482. doi: 10.1371/journal.pone.0005482. Epub 2009 May 8. PLoS One. 2009. PMID: 19424495 Free PMC article.
-
Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.Front Neuroendocrinol. 2008 Oct;29(4):507-19. doi: 10.1016/j.yfrne.2008.04.001. Epub 2008 Apr 29. Front Neuroendocrinol. 2008. PMID: 18522863 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous